Roche
Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer
June 30, 2020Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer
The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …
Roche’s rheumatoid arthritis drug Actemra shows no benefit in COVID-19 pneumonia
June 18, 2020Research and Development Actemra, COVID-19, Roche, coronavirus
Hope is waning around the efficacy of Roche’s Actemra (tocilizumab) following the release of results from an Italian study focusing …
NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer
June 15, 2020Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer
Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …
NICE reverses previous stance to recommend Roche’s Tecentriq in extensive-stage small-cell lung cancer
May 27, 2020Research and Development, Sales and Marketing NICE, Roche, lung cancer, tecentriq
NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new …
Genentech’s retiring R&D head to be replaced by MIT executive
May 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, appointment
Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …
NICE gives thumbs-up to Roche’s Kadcyla in HER2+ breast cancer sub-population
May 7, 2020Sales and Marketing Cancer, Kadcyla, NHS, NICE, Roche, UK, breast cancer
NICE has revealed that it has recommended the NHS use of Roche’s Kadcyla (trastuzumab emtansine) for HER2+ breast cancer in …
Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics
April 9, 2020Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma
Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …
Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia
March 24, 2020Manufacturing and Production Cancer, Roche, acute myeloid leukamia
Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …
COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches
March 24, 2020Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma
As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
FDA gives emergency authorisation to first coronavirus tests
March 17, 2020Manufacturing and Production, Sales and Marketing FDA, Roche, US, coronavirus
The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …
Venclyxto combo scores European approval for previously untreated chronic lymphocytic leukaemia
March 13, 2020Medical Communications, Sales and Marketing AbbVie, European Commission, Roche, Venclyxto, pharma
The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …
China approves Roche’s Actemra to fight severe complications stemming from coronavirus
March 5, 2020Sales and Marketing Actemra, China, Roche, coronavirus, pharma
China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …
NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma
February 26, 2020Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche
It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …
Roche’s experimental Alzheimer’s drug does not meet primary endpoint in clinical trials
February 10, 2020Sales and Marketing Alzheimer's, Roche, roche Alzheimer
Roche has said its experimental drug, gantenerumab, did not meet its primary endpoint in people who have an inherited form …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
